Are doctors using molecular hydrogen therapy in hospitals and clinics?
The short answer is yes—but mainly within clinical research, selected specialist settings and integrative or functional medicine practices.
Doctors and university researchers have investigated molecular hydrogen in human trials involving cardiac arrest, respiratory disease, metabolic health, exercise recovery and perioperative care. Some studies have taken place in hospitals in Japan, China, France and other countries.
However, molecular hydrogen therapy is not currently a routine NHS treatment, and it is not included in standard UK clinical guidelines for treating chronic disease.
That distinction is important.
A treatment being administered by doctors during a clinical study demonstrates genuine medical interest. It does not necessarily mean that the treatment has received broad regulatory approval, become standard hospital practice or accumulated enough evidence for routine prescribing.
Molecular hydrogen remains an emerging area of research. Early results are encouraging in several fields, but the evidence varies considerably according to the condition, delivery method and outcome being measured.
What Is Molecular Hydrogen Therapy?
Molecular hydrogen therapy involves introducing molecular hydrogen—written as H₂—into the body in a controlled way.
The two most common methods used in research are:
- Hydrogen inhalation: breathing a gas containing molecular hydrogen through a nasal cannula, mask or specialised respiratory system.
- Hydrogen-rich water: drinking water in which molecular hydrogen has been dissolved.
Researchers have also studied hydrogen-rich saline and topical applications, although these are less common outside experimental settings.
Molecular hydrogen is different from:
- Hydrogen peroxide
- Hydrogen sulphide
- Medical oxygen
- Alkaline water
- Industrial hydrogen
- Hydrogen breath testing
Because H₂ is exceptionally small and non-polar, it can diffuse rapidly through biological membranes. Researchers are studying whether it may influence oxidative balance, inflammatory signalling, mitochondrial function and cellular responses to stress.
For a complete introduction, read what hydrogen therapy is and how molecular hydrogen works.
Are Doctors Using Molecular Hydrogen Therapy in Hospitals?
Doctors have administered molecular hydrogen in hospital-based clinical studies. Published examples include research involving:
- Patients receiving post-cardiac-arrest care
- People experiencing acute myocardial infarction
- Hospitalised respiratory patients
- People undergoing surgery
- Patients receiving radiotherapy
- People with metabolic disorders
- Healthy research participants
This is legitimate clinical research. However, it should not be described as universal or mainstream hospital treatment.
There is an important difference between:
- Experimental clinical use: administered according to a research protocol;
- Specialist or compassionate use: offered in selected circumstances;
- Routine standard care: recommended in clinical guidelines and widely delivered through the health system.
Most medical applications of molecular hydrogen currently fall within the first category.
Medical Research in Japan
Japan has played a significant role in the development of molecular-hydrogen research.
A landmark 2007 laboratory study by Ohsawa and colleagues reported that molecular hydrogen could reduce particularly damaging reactive species in an experimental model. This publication helped stimulate international interest in H₂ biology.
Japanese doctors have subsequently investigated hydrogen inhalation in several clinical areas.
Post-cardiac-arrest care
The multicentre HYBRID II randomised clinical trial investigated inhaled hydrogen in unconscious patients who had been successfully resuscitated following an out-of-hospital cardiac arrest.
Patients received standard post-cardiac-arrest care, with the study examining whether adding inhaled H₂ could influence neurological outcomes.
The results suggested a possible improvement in favourable neurological recovery. However, the trial recruited fewer participants than originally planned and did not provide definitive evidence of effectiveness.
The study is important because it demonstrates that doctors have used carefully controlled hydrogen inhalation in a serious hospital setting. It does not establish hydrogen as standard treatment following cardiac arrest.
Acute myocardial infarction
Japanese researchers have also conducted a small pilot study involving people experiencing an acute ST-elevation myocardial infarction.
Participants received appropriate emergency cardiac care, and researchers investigated whether hydrogen inhalation might influence subsequent changes in heart structure and function.
The treatment appeared feasible, but the study was small. Larger trials are required before conclusions can be reached about meaningful clinical benefit.
Hydrogen inhalation must never delay emergency treatment for a suspected heart attack or cardiac arrest.
Medical Research in China
Chinese hospitals and universities have conducted clinical research involving hydrogen-and-oxygen gas mixtures.
One prominent area has been respiratory medicine.
Acute exacerbations of COPD
A multicentre randomised controlled trial compared hydrogen-and-oxygen inhalation with oxygen therapy in people hospitalised with an acute exacerbation of chronic obstructive pulmonary disease.
The researchers reported improvements in certain respiratory symptoms in the hydrogen-and-oxygen group, with an acceptable short-term safety profile.
This is a stronger study design than an uncontrolled case series. Nevertheless, one trial does not automatically establish a universal treatment protocol.
Questions still remain about:
- Which patients are most likely to benefit
- The optimal gas concentration
- Session frequency and duration
- Long-term outcomes
- Comparison with established respiratory interventions
- Whether results can be replicated internationally
Hospital research during COVID-19
Hydrogen-and-oxygen gas inhalation was also investigated in hospitalised COVID-19 patients.
A multicentre, open-label study reported improvements in breathlessness and some measures of disease severity. However, the open-label design meant that participants and researchers knew which treatment was being administered, increasing the possibility of bias.
COVID-19 treatment has also changed significantly since the early pandemic. Those results cannot automatically be applied to other respiratory illnesses or present-day care.
The study demonstrates clinical investigation—not proof that hydrogen therapy treats every breathing problem.
Research in European Hospitals
Molecular-hydrogen research is not limited to East Asia.
A French phase I study investigated a controlled mixture containing 3.6% molecular hydrogen in hospitalised patients with COVID-19. The principal purpose was to evaluate safety and tolerability rather than prove clinical effectiveness.
Twelve patients participated, and the researchers reported good short-term tolerance under the protocol studied. They concluded that larger controlled trials were justified.
This example illustrates how medical treatments normally progress:
- Laboratory research
- Animal studies
- Initial human safety studies
- Small pilot trials
- Larger randomised controlled trials
- Independent replication
- Regulatory and guideline review
- Possible adoption into routine care
Molecular hydrogen has reached different stages on this pathway for different conditions. It has not completed the pathway for broad routine medical use.
Are NHS Doctors Using Molecular Hydrogen Therapy?
Molecular hydrogen therapy is not currently a standard NHS treatment.
At the time of writing, there is no established NHS pathway routinely prescribing hydrogen inhalation or hydrogen-rich water for:
- Cardiovascular disease
- Cancer
- Diabetes
- Neurodegenerative disease
- Chronic inflammation
- Exercise recovery
- General wellbeing
- Healthy ageing
This does not mean NHS doctors have concluded that all hydrogen research lacks value. It means the evidence has not yet reached the level usually required for widespread clinical adoption.
Before the NHS routinely introduces a new intervention, decision-makers generally need convincing evidence concerning:
- Clinical effectiveness
- Patient safety
- Appropriate dosing
- Standardised equipment
- Long-term outcomes
- Cost-effectiveness
- Professional training
- Regulatory status
- Which patients should receive it
- How it compares with existing treatment
Molecular-hydrogen studies frequently use different concentrations, flow rates, delivery methods and treatment durations. This makes results harder to compare and prevents researchers from defining one universally accepted protocol.
What About Functional Medicine Doctors?
Some functional, integrative and longevity practitioners offer or recommend molecular hydrogen.
Their reasons may include its proposed relationship with:
- Oxidative-stress regulation
- Inflammatory signalling
- Mitochondrial function
- Exercise recovery
- Fatigue
- Metabolic health
- Healthy ageing
However, the term functional medicine practitioner does not itself guarantee that someone is a GMC-registered medical doctor.
In the UK, practitioners may have very different qualifications. Some are registered doctors, nurses or allied health professionals. Others may be nutritionists, health coaches or complementary therapists.
Before accepting medical advice, ask:
- Is the practitioner registered with the General Medical Council or another recognised professional regulator?
- What relevant clinical qualifications do they have?
- Are they familiar with your diagnosis and medication?
- Do they communicate with your GP or consultant?
- Are they making claims supported by human research?
- Do they explain limitations and possible risks?
- Would they discourage you from conventional treatment?
A responsible practitioner should never present molecular hydrogen as a guaranteed cure or pressure someone to stop prescribed care.
Why Are Some Clinicians Interested in H₂?
Several characteristics make molecular hydrogen an interesting research subject.
1. Rapid distribution
Because H₂ is exceptionally small, it can diffuse rapidly through biological membranes and reach tissues and cellular compartments.
This does not prove a therapeutic effect, but it makes the molecule biologically interesting.
2. Oxidative-stress signalling
Molecular hydrogen was initially described as a selective antioxidant. Current research suggests its actions may be more complex and could involve regulation of the body’s own antioxidant and stress-response systems.
Oxidative stress is relevant to many diseases, but that does not mean one intervention that affects oxidative markers will treat all those conditions.
3. Inflammatory pathways
Laboratory and human studies have reported changes in certain inflammatory biomarkers following hydrogen interventions.
Biomarkers can help researchers understand biological activity, but changes in laboratory measurements are not always accompanied by meaningful improvements in symptoms, disease progression or survival.
4. Mitochondrial research
Mitochondria generate most of the usable energy required by cells and participate in metabolism, stress signalling and programmed cell death.
Researchers are investigating whether molecular hydrogen influences mitochondrial function. Much of this evidence remains preclinical.
5. Generally favourable short-term tolerability
Published clinical studies have generally described molecular hydrogen as well tolerated under the conditions tested.
However, “generally well tolerated” is more accurate than “completely safe” or “without side effects.”
Many trials are small, protocols vary and long-term data remain limited. The absence of commonly reported serious reactions does not prove that every dose, machine or medical situation is risk-free.
What Conditions Are Doctors Researching?
Human research has examined molecular hydrogen in relation to several areas.
Cardiovascular and neurological emergencies
Hospital studies have investigated hydrogen following cardiac arrest, heart attack and cerebral ischaemia. These studies generally focus on limiting secondary tissue damage after circulation or oxygen delivery has been interrupted.
This is very different from claiming that home hydrogen therapy prevents heart attacks or strokes.
Respiratory conditions
Hydrogen-and-oxygen inhalation has been studied in hospitalised patients with COPD exacerbations and COVID-19.
The findings cannot be generalised to asthma, pulmonary fibrosis, respiratory infections or unexplained breathlessness without condition-specific evidence.
Anyone experiencing breathing difficulties requires appropriate medical assessment.
Metabolic health
Trials involving hydrogen-rich water or inhalation have examined blood glucose, cholesterol, liver fat and inflammatory biomarkers.
Some studies have reported modest improvements, but hydrogen has not replaced established treatment for diabetes, high cholesterol, obesity or fatty-liver disease.
Exercise and recovery
Researchers have investigated whether H₂ influences fatigue, soreness, oxidative-stress markers and exercise performance.
Results are mixed, and many studies include small groups of healthy participants. This field may be relevant to wellness and sports recovery, but it should not be confused with evidence for treating disease.
Perioperative care
Some medical teams have studied hydrogen inhalation around the time of surgery.
A 2024 study involving patients undergoing glioma surgery reported reduced postoperative brain oedema in the hydrogen-and-oxygen group. Further research is required to determine whether this produces consistent improvements in recovery or longer-term outcomes.
Cancer-support research
Small human studies have examined quality of life and treatment-related oxidative stress in people receiving cancer care.
Molecular hydrogen has not been proven to treat cancer, shrink tumours or improve survival. Anyone undergoing oncology treatment should consult their oncology team before introducing a complementary therapy.
Is Molecular Hydrogen Therapy Scientifically Proven?
Molecular hydrogen has a genuine scientific evidence base, including:
- Laboratory studies
- Animal experiments
- Human feasibility studies
- Controlled clinical trials
- Systematic and narrative reviews
- Registered ongoing trials
However, saying that something has been scientifically studied is not the same as saying it has been conclusively proven for every advertised purpose.
The strength of evidence depends on the specific question.
For example:
- Has molecular hydrogen been administered to humans in clinical studies? Yes.
- Have doctors used it in hospital research? Yes.
- Has it generally appeared tolerable under studied conditions? Yes.
- Is it routine NHS treatment? No.
- Is it proven to cure chronic diseases? No.
- Do we know the ideal dose for every condition? No.
- Are larger independent trials needed? Yes.
This balanced answer is more credible than either dismissing the entire field or presenting preliminary findings as settled medicine.
Is Hydrogen Inhalation Safe?
Clinical studies have generally reported favourable short-term tolerability, but safety has two distinct components.
Biological tolerability
This concerns how the body responds to molecular hydrogen at the concentration, duration and delivery method being studied.
Possible issues cannot be fully defined because:
- Many trials are small.
- Safety reporting varies.
- Long-term exposure is less well studied.
- Vulnerable groups are under-represented.
- Results from one protocol may not apply to another.
Equipment and environmental safety
Hydrogen is flammable when it accumulates in air within certain concentrations and an ignition source is present.
Safe use therefore depends on:
- Appropriate equipment
- Reliable gas generation
- Correct tubing and connections
- Adequate ventilation
- Following the manufacturer’s instructions
- Avoiding cigarettes, flames, sparks and heat sources
- Appropriate supervision
- Regular maintenance
- Not modifying internal safety systems
Read our complete guide to hydrogen therapy safety, side effects and responsible equipment use.
Should You Speak to Your Doctor Before Using Hydrogen Therapy?
Professional advice is particularly important if you:
- Have a diagnosed medical condition
- Take prescribed medication
- Have a respiratory or cardiovascular disorder
- Use supplemental oxygen
- Have recently undergone surgery
- Are receiving cancer treatment
- Are pregnant or breastfeeding
- Are considering hydrogen for a child
- Have an implanted medical device
- Plan to alter an existing treatment programme
Do not stop or change prescribed treatment because of molecular-hydrogen research without consulting the responsible clinician.
It may help to take the actual published study to your appointment rather than relying on a product advertisement. Ask whether the research involved people with your condition and whether the delivery method and protocol match what you are considering.
How to Recognise a Responsible Hydrogen Provider
A responsible provider should:
- Distinguish research findings from proven treatment
- Avoid guaranteed outcomes
- Never claim hydrogen cures every disease
- Encourage appropriate medical advice
- Explain what the machine produces
- Provide clear operating and safety instructions
- Explain ventilation and ignition precautions
- Offer transparent specifications
- Provide warranty and after-sales support
- Avoid encouraging customers to discontinue medication
Be cautious when a provider relies entirely on testimonials or applies the results of one small study to numerous unrelated conditions.
Credibility comes from presenting both the potential and the limitations of the science.
The Future of Molecular Hydrogen in Medicine
Molecular-hydrogen research has progressed beyond laboratory theory. Doctors and researchers have administered H₂ in real clinical trials, including hospital-based studies.
That is meaningful progress.
However, several challenges remain before molecular hydrogen could become routine medical care:
- Larger patient populations
- Standardised gas concentrations
- Consistent dose reporting
- Agreement on session length and frequency
- Better long-term safety data
- Independent replication
- Trials measuring clinically meaningful outcomes
- Comparison with established treatment
- Clear regulatory frameworks
- Evidence of cost-effectiveness
Some proposed applications may eventually prove useful. Others may produce little or no clinical benefit when examined in larger trials. That uncertainty is a normal part of medical research.
Final Answer: Are Doctors Using Molecular Hydrogen Therapy?
Yes. Doctors and clinical researchers are using molecular hydrogen in controlled studies and selected specialist settings.
Published hospital research has examined H₂ in connection with cardiac arrest, heart attack, respiratory disease, surgery, metabolic health and treatment-related quality of life.
Some functional and integrative practitioners also include molecular hydrogen in broader wellness programmes.
But molecular hydrogen is not yet routine NHS medicine, nor is it an established treatment for the many conditions sometimes associated with it online.
The most accurate conclusion is:
Molecular hydrogen is a credible and developing field of clinical research with encouraging early findings, but most medical applications remain investigational.
At H2=E, we believe the best way to build trust in hydrogen therapy is through transparency. That means recognising genuine clinical progress while being equally clear about uncertainty, limitations and the need for stronger research.
Frequently Asked Questions
Do hospitals use molecular hydrogen?
Some hospitals have administered molecular hydrogen during clinical research, particularly in Japan, China and selected European studies. This does not mean it is routine hospital treatment worldwide.
Do NHS hospitals offer hydrogen therapy?
Molecular hydrogen therapy is not currently a standard NHS treatment or a routine part of UK clinical guidelines.
Can a doctor prescribe molecular hydrogen?
This depends on the country, regulatory framework and intended use. In the UK, hydrogen inhalation is not routinely prescribed as a standard treatment for chronic disease.
Is hydrogen therapy approved in Japan?
Japan has conducted important clinical research into molecular hydrogen. Claims that it is universally approved or mainstream for numerous diseases are misleading. Its status depends on the specific application and research protocol.
Do functional medicine doctors recommend hydrogen therapy?
Some do, but qualifications vary. Confirm whether the practitioner is a registered medical professional and whether their recommendations are supported by relevant human evidence.
Is molecular hydrogen safe with medication?
No broad interaction pattern has been established, but interaction evidence is incomplete. Do not change medication without consulting the prescribing clinician.
Scientific references
- Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007. PubMed
- Tamura T, et al. Efficacy of inhaled hydrogen on neurological outcome following brain ischaemia during post-cardiac-arrest care: HYBRID II. eClinicalMedicine. 2023. PubMed
- Zheng ZG, et al. Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease. Respiratory Research. 2021. PubMed
- Guan WJ, et al. Hydrogen/oxygen mixed-gas inhalation improves disease severity and dyspnoea in patients with COVID-19. Journal of Thoracic Disease. 2020. PubMed
- Salomez-Ihl C, et al. H₂ inhalation therapy in patients with moderate COVID-19: a phase I study. 2024. PubMed
- Hu Y, et al. Effects of perioperative hydrogen inhalation on brain oedema in patients undergoing glioma surgery. 2024. PubMed
This article is for educational purposes and is not medical advice. H2=E does not claim that molecular hydrogen prevents, treats or cures disease. Hydrogen therapy should not replace medical assessment, prescribed medication or conventional treatment.
